Startseite Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review

  • Oren Lapid EMAIL logo , Jan J. van Wingerden und Leon Perlemuter
Veröffentlicht/Copyright: 24. Mai 2013

Abstract

Objective: A systematic review to assess the efficacy of tamoxifen in the management of idiopathic pubertal gynecomastia.

Data sources: Searches were conducted using the databases of Medline (search engine PubMed) and Web of Science®.

Study selection: Studies reporting the use of Tamoxifen for the treatment of gynecomastia in adolescents.

Outcome measure: Resolution of gynecomastia.

Results: A total of 164 publications were found; 59 were selected for retrieval and six were included in the review. There were no randomized controlled studies; the studies found have methodological flaws but show promising results. No clinical side-effects were reported or observed.

Conclusion: Tamoxifen may be effective for the treatment of pubertal gynecomastia, and it seems safe to use. Randomized controlled studies are necessary to confirm this indication.


Corresponding author: Oren Lapid, MD, Department of Plastic, Reconstructive and Hand Surgery, Academic Medical Center, University of Amsterdam, Meibergdreef 9, PO Box 22660, 1100 DD Amsterdam, the Netherlands, Phone: +31 20 566-4039, Fax: +31 20 691-7549, E-mail:

Conflict of interest statement

Financial interest: None to declare.

References

1. Rohrich RJ, Ha RY, Kenkel JM, Adams WP Jr. Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction. Plast Reconstr Surg 2003;111:909–23, 924–5.10.1097/01.PRS.0000042146.40379.25Suche in Google Scholar

2. Braunstein GD. Clinical practice. Gynecomastia. N Engl J Med 2007;357:1229–37.10.1056/NEJMcp070677Suche in Google Scholar

3. Nordt CA, Divasta AD. Gynecomastia in adolescents. Curr Opin Pediatr 2008;20:375–82.10.1097/MOP.0b013e328306a07cSuche in Google Scholar

4. Neuman JF. Evaluation and treatment of gynecomastia. Am Fam Physician 1997;55:1835–44, 1849–50.Suche in Google Scholar

5. Devalia HL, Layer GT. Current concepts in gynaecomastia. Surgeon 2009;7:114–9.10.1016/S1479-666X(09)80026-7Suche in Google Scholar

6. Fairlamb D, Boesen E. Gynaecomastia associated with gonadotrophin-secreting carcinoma of the lung. Postgrad Med J 1977;53:269–71.10.1136/pgmj.53.619.269Suche in Google Scholar PubMed PubMed Central

7. Kunath F, Keck B, Antes G, Wullich B, Meerpohl JJ. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Med 2012;10:96.10.1186/1741-7015-10-96Suche in Google Scholar PubMed PubMed Central

8. Viani GA, Bernardes Da Silva LG, Stefano EJ. Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy? Int J Radiat Oncol Biol Phys 2012;83: e519–24.10.1016/j.ijrobp.2012.01.036Suche in Google Scholar PubMed

9. Alagaratnam TT. Treating puberty gynecomastia. J R Coll Gen Pract 1987;37:178.Suche in Google Scholar

10. Derman O, Kanbur N, Kutluk T. Tamoxifen treatment for pubertal gynecomastia. Int J Adolesc Med Health 2003;15:359–63.10.1515/IJAMH.2003.15.4.359Suche in Google Scholar

11. Derman O, Kanbur N, Tokur TE. The effect of tamoxifen on sex hormone binding globulin in adolescents with pubertal gynecomastia. J Pediatr Endocrinol Metabol 2004:17:1115–19.10.1515/JPEM.2004.17.8.1115Suche in Google Scholar PubMed

12. Derman O, Kanbur N, Kilic I, Kutluk T. Long-term follow-up of tamoxifen treatment in adolescents with gynecomastia. J Pediatr Endocrinol Metabol 2008;21:449–54.10.1515/JPEM.2008.21.5.449Suche in Google Scholar PubMed

13. König R, Schönberger W, Neumann P, Benes P, Grimm W. Treatment of marked pubertal gynecomastia with tamoxifen. Klin Padiatr 1987;199:389–91.10.1055/s-2008-1026828Suche in Google Scholar PubMed

14. Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 2004;145:71–6.10.1016/j.jpeds.2004.03.057Suche in Google Scholar PubMed

15. Caceres Narizzano O. Diagnosis and treatment of gynecomastia. [Spanish] Diagnostico Y Terapeutica De Las Ginecomastias. Endocrinologia 1995;42:61.Suche in Google Scholar

16. Sullivan D, Chung KC, Eaves FF 3rd, Rohrich RJ. The level of evidence pyramid: indicating levels of evidence in Plastic and Reconstructive Surgery articles. Plast Reconstr Surg 2011;128:311–4.10.1097/PRS.0b013e3182195826Suche in Google Scholar PubMed

17. Nydick M, Bustos J, Dale JH Jr., Rawson RW. Gynecomastia in adolescent boys. J Am Med Assoc 1961;178:449–54.10.1001/jama.1961.03040440001001Suche in Google Scholar PubMed

18. Kreher NC, Eugster EA, Shankar RR. The use of tamoxifen to improve height potential in short pubertal boys. Pediatrics 2005;116:1513–5.10.1542/peds.2005-0577Suche in Google Scholar PubMed

Received: 2013-2-6
Accepted: 2013-4-22
Published Online: 2013-05-24
Published in Print: 2013-10-01

©2013 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Review article
  4. Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review
  5. Images in pediatric endocrinology
  6. Solitary median maxillary central incisor, a clinical predictor of hypoplastic anterior pituitary, ectopic neurohypophysis and growth hormone deficiency
  7. A rare case of granuloma annulare in a 6-year-old child with type 1 diabetes
  8. Original articles
  9. The arginine stimulation test: timing of peak is not a helpful parameter in the diagnosis of growth hormone deficiency
  10. The relationship between adiposity and stature in prepubertal children with celiac disease
  11. Influence of micronutrient status and socioeconomic gradient on growth indices of 2–18-year-old Indian girls
  12. Phosphotyrosine phosphatases in GH-stimulated skin fibroblasts from children with idiopathic short stature
  13. The relation between salivary cortisol and the metabolic syndrome score in girls
  14. Association of vitamin D concentrations with adiposity indices among preadolescent children in Korea
  15. Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children
  16. Characteristics of infants at risk of hypoglycaemia secondary to being ‘infant of a diabetic mother’
  17. Parental dyadic coping in families of children and adolescents with type 1 diabetes
  18. Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome
  19. Effect of insulin therapy on IGF-1 level in children with new-onset type 1 diabetes mellitus: a comparison between DKA and non-DKA
  20. Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias
  21. Sexual development in prepubertal obese boys: a 4-year longitudinal study
  22. Genetic diagnosis of one family with incomplete clinical data
  23. Patient reports
  24. Complete androgen insensitivity syndrome and discordant Müllerian remnants: two cases with novel mutation in the androgen receptor
  25. Psychosexual outcomes in three siblings with partial androgen insensitivity syndrome: impact of nature versus nurture
  26. Ambiguous genitalia in a 48, XXYY newborn: a casual relationship or a coincidence?
  27. Gonadal function of beta-thalassemics following stem cell transplantation conditioned with myeloablative and reduced intensity regimens
  28. Significant testicular enlargement in a 6.5-year-old boy with monorchism and testicular microlithiasis
  29. Report of the first case of precocious puberty in Rett syndrome
  30. Type II vitamin D-dependent rickets with diabetic ketoacidosis
  31. Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent
  32. A rare association between Rathke’s cyst and hypophysitis in a patient with delayed sex development and growth failure
  33. Diabetes mellitus with Laron syndrome: case report
  34. Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood
  35. Rare cases of autoimmune hypothyroidism in young children
  36. Cushing syndrome related to leukemic infiltration of the central nervous system: a case report and a possible role of LIF
  37. Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy
  38. Identification of a novel homozygous mutation (S144I) in a Malay patient with maple syrup urine disease
  39. Virilization in two pre-pubertal children exposed to topical androgen
  40. A family with Camurati-Engelman disease. The role of the missense p.R218C mutation in TGFB1 in bones and endocrine glands
  41. Short communications
  42. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes
  43. Assessment of contractility and myocardial function in small and appropriate for gestational age premature neonates using the stress-velocity relationship and tissue Doppler imaging immediately after birth
  44. Letter to the Editors
  45. Homeostasis model assessment of insulin resistance may not be reliable to evaluate insulin sensitivity in young obese children
  46. Type 1 diabetes in women with endometriosis: what is the risk of occurrence?
  47. How should we manage vitamin D-deficient adolescents?
  48. Should neonatal hyperparathyroidism associated with mucolipidosis II/III be treated pharmacologically?a
Heruntergeladen am 7.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0052/html
Button zum nach oben scrollen